New Obesity Drugs Defy Logic – And Succeed
Drugs that both activate and block the GIP receptor reduce weight through different brain mechanisms, offering a new direction for targeted obesity treatments. Drugs that target the receptors for the hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) have proven effective in treating obesity and type 2 diabetes. While GLP-1 and GIP receptor agonists […]
News Article – WHO Leaning Toward Adding Obesity Drugs for Adults to Essential Medicines List: Reuters
May 2, 2025 According to the provided text from Fox News, the World Health Organization (WHO) is planning to endorse the use of GLP-1 weight-loss medications for adults as a strategy to combat the global obesity crisis. This support aims to improve access to these drugs, particularly in low- and middle-income countries, where a significant portion of the world’s obese population resides. The […]
Healthcare News – Cigna doubles down on GLP-1 support programs with 2 new launches
The company’s health services division Evernorth is unveiling new programs in a reliable growth area: assuaging payer concerns around GLP-1 coverage. Dive Brief: This article focuses on Cigna’s strategies regarding the growing demand for GLP-1 weight loss medications. Cigna’s health services division, Evernorth, is launching two new support programs aimed at assisting patients and easing concerns for payers regarding the high […]